We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+42.48%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$9.22M
Cap. Flow
-$20.8M
Cap. Flow %
-9.11%
Top 10 Hldgs %
62.39%
Holding
90
New
18
Increased
18
Reduced
19
Closed
27

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$13.7M
2
MRK icon
Merck
MRK
+$9.87M
3
DHR icon
Danaher
DHR
+$3.66M
4
SNY icon
Sanofi
SNY
+$2.9M
5
MDT icon
Medtronic
MDT
+$2.48M

Top Sells

Rank Stock Value
1
QCP
Quality Care Properties, Inc.
QCP
+$23.1M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.94M
3
AERI
Aerie Pharmaceuticals
AERI
+$6.83M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.25M
5
NVRO
NEVRO CORP.
NVRO
+$3.78M

Sector Composition

Rank Sector Weight
1 Healthcare 78.99%
2 Miscellaneous 12.59%
3 Industrials 7.51%
4 Communication Services 0.5%
5 Real Estate 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
76
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-9,536
Closed -$375K
CYAD
77
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
– –
-12,840
Closed -$382K
GBT
78
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-13,800
Closed -$624K
IIN
79
DELISTED
IntriCon Corporation
IIN
– –
-12,000
Closed -$484K
MGLN
80
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-3,000
Closed -$288K
MYOK
81
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-25,950
Closed -$1.29M
IMMU
82
DELISTED
Immunomedics Inc
IMMU
– –
-55,000
Closed -$1.3M
AKRX
83
DELISTED
Akorn Inc
AKRX
– –
-70,000
Closed -$1.16M
ATHN
84
DELISTED
Athenahealth, Inc.
ATHN
– –
-16,000
Closed -$2.55M
TSRO
85
DELISTED
TESARO, Inc.
TSRO
– –
-52,523
Closed -$2.34M
QCP
86
CALL
DELISTED
Quality Care Properties, Inc.
QCP
– –
-20,000
Closed -$430K
QCP
87
DELISTED
Quality Care Properties, Inc.
QCP
– –
-1,074,080
Closed -$23.1M
QCP
88
PUT
DELISTED
Quality Care Properties, Inc.
QCP
– –
-1,800
Closed -$38.7K
ZGNX
89
CALL
DELISTED
Zogenix, Inc.
ZGNX
– –
-10,000
Closed -$442K
ZGNX
90
PUT
DELISTED
Zogenix, Inc.
ZGNX
– –
-123,300
Closed -$5.45M
1 2 3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Eversept Partners held 90 positions worth $228M, up 4.2% from $219M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners withdrew a net $20.8M in Q3 2018, closing 27 positions and reducing 19 holdings. Its most notable exit was Quality Care Properties, Inc., an estimated $23.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 73% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Eversept Partners opened a new position in Merck worth $10.6M.

  • Eversept Partners's largest Q3 2018 buy was Merck: 154,894 shares worth $10.6M.
  • Eversept Partners added most to Zogenix, Inc. in Q3 2018, an estimated $13.7M increase.
  • Eversept Partners's biggest Q3 2018 reduction was Aerie Pharmaceuticals, cutting an estimated $6.83M.
  • Eversept Partners fully exited Quality Care Properties, Inc. in Q3 2018, selling an estimated $23.1M.
  • Eversept Partners's ten largest holdings make up 62% of its $228M portfolio in Q3 2018.
  • Eversept Partners opened 18 new positions and closed 27 in Q3 2018.
  • Eversept Partners's portfolio value rose 4.2% quarter-over-quarter to $228M.

Based on Eversept Partners's 13F filing for Q3 2018, filed 14 Nov 2018.